News

News

 

 

Successful collaboration achieves accurate prediction of microfluidic bead production

9th June 2020

Read more about LEXMA's unique software – MOEBIUS – which simulates the production of PLGA droplets in Aqua-Phase, and accurately predicts the trends in bead manufacture reported by Dolomite Microfluidics in the "Continuous Synthesis of Monodisperse PLGA Particles using Droplets" Application Note.

Read more

Successful collaboration achieves accurate prediction of microfluidic bead production

Microfluidics enables reliable siRNA drug delivery for inflammatory diseases and tumor targeting

4th May 2020

Researchers in the Department of Pharmacy at the Ludwig Maximilian University of Munich are using chips from Dolomite Microfluidics to reliably and consistently manufacture monodisperse nanoparticles for targeted delivery of small interfering RNA (siRNA) therapeutics.

Read more

Microfluidics enables reliable siRNA drug delivery for inflammatory diseases and tumor targeting

FACS sorting droplets: Expression assays in double emulsions using the Dolomite µEncapsulator

8th April 2020

Read more about the recent proof of concept study performed by Dr Gurinder Vinner to show the encapsulation of a fluorophore in water-in-oil-in-water droplets.

Read more

FACS sorting droplets: Expression assays in double emulsions using the Dolomite µEncapsulator

Dolomite Microfluidics and Mologic collaborate to scale-up manufacture of nanoparticles for COVID-19 diagnostic tests

2nd April 2020

Dolomite Microfluidics is pleased to announce a new collaboration with Mologic to combine ground-breaking diagnostic technology with continuous flow microfluidic manufacturing processes to accelerate the validation and wide-release of Mologic’s COVID-19 diagnostic test.

Read more

Dolomite Microfluidics and Mologic collaborate to scale-up manufacture of nanoparticles for COVID-19 diagnostic tests

A COVID-19 update to all our customers and members of the scientific community

18th March 2020

A COVID-19 update to all our customers and members of the scientific community. We would like to reassure you that, at this challenging time, we are indeed fully operational and will provide the same level of support as usual. Furthermore, we are pleased to announce that we will extend our educational online content. Please read this article & stay tuned for more information on this!

Read more